It has been also shown that PCa-derived CXCL5 can recruit CXCR2-expressing MDSCs in a mouse model of PCa and inhibition of MDSCs through blocking of CXCL5-CXCR2 axis can restore anti-tumor activities [109]. The gene discussed is CXCR2; the disease is posterior cortical atrophy.